🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "targeted measures to deal with cost of living issues" in next month's Budget.

In comments to media outlets, she noted that reducing price rises is a joint task of both the administration and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven advanced economies this year and next.

Possible Utility Cost Interventions

Sources suggest the government could intervene to lower utility costs, for instance by cutting the present 5% level of VAT applied on energy.

Another option is to lower some of the regulatory levies currently included in household expenses.

Fiscal Limitations and Analyst Predictions

The government will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for such actions.

The expectation from most economists is that the Chancellor will have to announce tax rises or spending cuts in order to adhere to her declared borrowing rules.

Previously on the same day, estimates indicated there was a twenty-two billion pound deficit for the chancellor to resolve, which is at the more modest range of projections.

"It is a joint responsibility between the central bank and the administration to bear down further on some of the drivers of price increases," Reeves told the BBC in Washington, at the conferences of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Issues

While a great deal of the focus has been on probable tax rises, the Treasury chief said the latest information from the OBR had not changed her vow to election pledges not to raise rates on income tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing geopolitical and trade tensions for the fiscal tax moves, probably to be directed on those "wealthiest."

Global Economic Disputes

Commenting on apprehensions about the UK's trade ties with China she said: "The UK's security interests always come first."

Last week's statement by Chinese authorities to strengthen export controls on rare earths and other materials that are key for advanced tech manufacturing led American leader the US President to threaten an further 100% import tax on goods from China, increasing the prospect of an all-out commercial conflict between the two global powers.

The American finance chief described China's decision "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the US offer to join its battle with the Asian nation, the Chancellor said she was "deeply worried" by Chinese actions and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the move was "bad for the international commerce and causes additional obstacles."

"In my view there are areas where we must address China, but there are also significant opportunities to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that equilibrium correct."

The chancellor also stated she was working with G7 counterparts "regarding our own essential resources strategy, so that we are reduced dependence."

NHS Drug Pricing and Investment

The Chancellor also recognized that the cost the National Health Service pays for drugs could rise as a result of ongoing negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or canceling projects in the United Kingdom, with several attributing the insufficient payments they are getting.

Last month, the Science Minister said the cost the NHS pays for medicines would need to increase to halt firms and drug research funding departing from the United Kingdom.

The Chancellor stated to media: "It has been observed as a result of the cost structure, that medical research, new drugs have not been offered in the United Kingdom in the manner that they are in other European countries."

"The objective is to ensure that patients getting treatment from the NHS are can receive the top critical drugs in the globe. And so we are examining these issues, and... aiming to secure increased funding into Britain."